Giglioli C, Valente S, Margheri M, Comeglio M, Chiostri M, Romano S M, Saletti E, Falai M, Chechi T, Gensini G F
Catheterisation Laboratory, Heart and Vessel Department, University of Florence, Florence, Italy.
Int J Cardiol. 2009 Jan 24;131(3):362-9. doi: 10.1016/j.ijcard.2007.10.032. Epub 2008 Jan 18.
Percutaneous coronary intervention (PCI) is considered to be the optimal type of revascularization in patients with ST-segment elevation myocardial infarction (STEMI). However, the long-term effectiveness of this procedure can be reduced by restenosis. This investigation was aimed at a prospective evaluation, in a group of STEMI patients of "the real world" (not involved in randomised trials), of the angiographic restenosis rate at a 6-month follow-up, and at identifying the relationship between restenosis and the patients' characteristics.
Our study population consisted of 123 patients with STEMI submitted to primary PCI to then undergo stress echocardiography 3 months after PCI and an angiographic evaluation at a 6-month follow-up.
a) In real life the restenosis rate is quite high (42.3%); b) no correlation was found between patients' clinical characteristics and restenosis; c) restenosis rate was higher in patients with bare metal stents than in those with drug-eluting stents (55.8% vs. 11.1%; p<0.001); in patients with longer stents (21.6+/-8.62 vs 18.1+/-6.34 mm, p=0.015) and when more than one stent was implanted. Moreover, a consistent number of patients showed restenosis though asymptomatic.
Our data suggest that primary PCI is associated with a high incidence of angiographic restenosis. No correlation was found between patients' clinical characteristics and restenosis. The length and the number of implanted stents seem to be associated with a more probable restenosis at six-month angiographic evaluation. Drug-eluting stent implantation seems to be associated with a lower incidence of restenosis even in STEMI patients.
经皮冠状动脉介入治疗(PCI)被认为是ST段抬高型心肌梗死(STEMI)患者血运重建的最佳方式。然而,该手术的长期有效性可能会因再狭窄而降低。本研究旨在对一组“现实世界”(未参与随机试验)的STEMI患者进行前瞻性评估,观察6个月随访时的血管造影再狭窄率,并确定再狭窄与患者特征之间的关系。
我们的研究人群包括123例接受直接PCI的STEMI患者,这些患者在PCI术后3个月接受负荷超声心动图检查,并在6个月随访时进行血管造影评估。
a)在现实生活中,再狭窄率相当高(42.3%);b)未发现患者临床特征与再狭窄之间存在相关性;c)裸金属支架患者的再狭窄率高于药物洗脱支架患者(55.8%对11.1%;p<0.001);支架较长的患者(21.6±8.62对18.1±6.34mm,p=0.015)以及植入多个支架的患者再狭窄率更高。此外,相当数量的患者虽无症状但出现了再狭窄。
我们的数据表明,直接PCI与较高的血管造影再狭窄发生率相关。未发现患者临床特征与再狭窄之间存在相关性。在6个月血管造影评估中,植入支架的长度和数量似乎与更可能发生的再狭窄相关。即使在STEMI患者中,药物洗脱支架植入似乎也与较低的再狭窄发生率相关。